美国食品药品监督管理局（FDA）近日确认，已获知医疗器械制造商Merit Medical Systems主动向受影响客户发出通知函，建议立即停止使用并下架其部分透析导管产品。该举措涉及特定批次的透析导管在临床及销售环节的暂停使用。
美国食品药品监督管理局（FDA）近日确认，已获知医疗器械制造商Merit Medical Systems主动向受影响客户发出通知函，建议立即停止使用并下架其部分透析导管产品。该举措涉及特定批次的透析导管在临床及销售环节的暂停使用。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.